About: Thomas Klingebiel

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Thomas Klingebiel Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

German oncologist

Attributes	Values
rdf:type	Item
field of work	wds:Q23015767-22c9e977-e4e3-4070-bd3d-6644c942c436 wds:Q23015767-56c15266-de4b-4258-a5c0-3cb09b6e62ab wds:Q23015767-5e06e3f4-151b-4705-8d53-ee5e96290720 wds:Q23015767-fb9be860-ec58-45be-bf98-a530fd4d66fd
field of work	pediatrics medicine hematooncology wd:Q106084266
description	Duits oncoloog (nl) German oncologist (en) oncólogo alemán (es) oncólogu alemán (ast) عالم أورام ألماني (ar) Lékař, univerzitní profesor; dětský onkolog a hematoonkolog. (cs)
rdfs:label	Thomas Klingebiel (ca) Thomas Klingebiel (cs) Thomas Klingebiel (de) Thomas Klingebiel (en) Thomas Klingebiel (es) Thomas Klingebiel (fr) Thomas Klingebiel (nl) Thomas Klingebiel (sl) Thomas Klingebiel (sq) Thomas Klingebiel (ast)
skos:prefLabel	Thomas Klingebiel (ca) Thomas Klingebiel (cs) Thomas Klingebiel (de) Thomas Klingebiel (en) Thomas Klingebiel (es) Thomas Klingebiel (fr) Thomas Klingebiel (nl) Thomas Klingebiel (sl) Thomas Klingebiel (sq) Thomas Klingebiel (ast)
name	Thomas Klingebiel (ca) Thomas Klingebiel (cs) Thomas Klingebiel (de) Thomas Klingebiel (en) Thomas Klingebiel (es) Thomas Klingebiel (fr) Thomas Klingebiel (nl) Thomas Klingebiel (sl) Thomas Klingebiel (sq) Thomas Klingebiel (ast)
given name	wds:Q23015767-06CA797A-5EA8-46B4-8BD6-E97E381A89D9
given name	Thomas
instance of	wds:Q23015767-B4DE88DF-18A9-409F-929B-20B1624902A9
NL CR AUT ID	wds:Q23015767-9DAD11B6-0A95-41FD-A54C-D62E6D844E0A
instance of	Homo sapiens
NL CR AUT ID	xx0300263
award received	wds:Q23015767-96146452-442c-66db-ba71-f2b5ff10a310
award received	Robert Pfleger Research Award
occupation	wds:Q23015767-0aa97ca5-44b1-bc7a-99b3-2b8467c0bef4 wds:Q23015767-674e70f3-67e9-47e6-990c-58fa51e961dd wds:Q23015767-99ff8c62-ff8e-4983-bb03-55a2e02a947c wds:Q23015767-f5dc0e90-5e03-4571-873b-8bcbdd0f6dfa
languages spoken, written or signed	wds:Q23015767-48F205C3-05CC-4A06-9C62-A98DFC0098F0
place of birth	wds:Q23015767-14712429-9dad-491a-8b4f-59846b561b1c
sex or gender	wds:Q23015767-43AAC859-FDB8-4394-8D70-1EA970B8F263
VIAF ID	wds:Q23015767-340b9204-154a-4ed2-ac4b-57de3979bfe3
country of citizenship	wds:Q23015767-D2D63341-4A57-495B-88DC-1ADD244D4713
date of birth	wds:Q23015767-4B13E7C3-7FEA-4AC5-A582-138CACAFA095
VIAF ID	http://viaf.org/viaf/8168446420755942978
occupation	university teacher oncologist physician pediatrician
languages spoken, written or signed	German
place of birth	Fulda
sex or gender	male
VIAF ID	8168446420755942978
country of citizenship	Germany
date of birth	1953-01-01 00:00:00Z (xsd:dateTime)
is owl:sameAs of	Thomas Klingebiel
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q23015767
is author of	Odontoid infiltration and spinal compression in Farber Disease: reversal by haematopoietic stem cell transplantation Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. Osteosarcoma in patients with Rothmund-Thomson syndrome. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model. Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia. Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software